Atrás
Rango del Día
$33.79
$35.65
Rango de 52 Semanas
$3.72
$43.73
Volumen
2,344,103
Promedio 50D / 200D
$37.17
/
$23.42
Cierre Anterior
$33.38
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -17.5 | 0.4 |
| P/B | 9.0 | 2.9 |
| ROE % | -73.7 | 3.8 |
| Net Margin % | — | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.4 | 0.2 |
Precio Objetivo de Analistas
Hold
$48.13
+35.9%
Low: $35.00
High: $60.00
EPS Futuro
-$2.14
Ingresos Est.
18 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$4.76
$0.57 – $12.01
|
1.7 B | 6 |
| FY2029 |
$3.07
$0.37 – $7.75
|
1.3 B | 6 |
| FY2028 |
$1.05
$0.23 – $2.35
|
760 M | 8 |
Puntos Clave
Debt/Equity of 0.40 — conservative balance sheet
Negative free cash flow of -266.00M
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-73.70%
ROIC-28.11%
Net MarginN/A
Op. MarginN/A
Seguridad
Debt / Equity
0.40
Current Ratio14.23
Interest Coverage-108.87
Valoración
P/E Ratio
-17.47
P/B Ratio9.03
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -328.94M |
| ROE | -73.70% | ROA | -35.08% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -266.00M |
| ROIC | -28.11% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.40 | Current Ratio | 14.23 |
| Interest Coverage | -108.87 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -17.47 | P/B Ratio | 9.03 |
| P/S Ratio | N/A | PEG Ratio | -2.00 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 5.75B | Enterprise Value | 5.69B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -328.94M | -255.86M | -192.41M | -140.24M | -72.27M |
| EPS (Diluted) | -2.55 | -2.46 | -2.42 | -2.26 | -1.85 |
| Gross Profit | -4.62M | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating Income | -333.36M | -275.94M | -208.13M | -147.84M | -75.55M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 937.61M | 327.90M | 313.44M | 300.81M | 232.09M |
| Total Liabilities | 301.24M | 71.61M | 55.64M | 45.08M | 17.91M |
| Shareholders' Equity | 636.37M | 256.29M | 257.80M | 255.74M | 214.18M |
| Total Debt | 253.15M | 17.47M | 18.85M | 19.65M | 3.16M |
| Cash & Equivalents | 312.01M | 98.17M | 53.23M | 139.89M | 219.68M |
| Current Assets | 910.36M | 296.47M | 270.77M | 264.97M | 222.63M |
| Current Liabilities | 63.95M | 55.71M | 38.17M | 26.85M | 17.08M |